Welcome to the first international network created by pharmacy students for all their friends in pharmacy! It's designed to be a place that brings your distant friends closer, promotes your work, expresses your thoughts and makes everyday communication & learning more vivid and fun...
Sign up» Network search»The release of diabetes drug alogliptin, manufactured by Takeda Pharmaceutical Co., may be delayed by at least two years.
A team of German researchers may have found a new chemical compound, currently known as XBD173, that controls panic attacks without the side affects that accompany many current anti-anxiety treatments.
Skip to [ Story Content and jump story attachments ] Printable version E-mail to a friend External weblinks Manufacturing Chemist is not responsible for the content of external internet sites.
French pharmaceutical group Sanofi-Aventis is to restructure its research and development division to boost productivity and increase innovation, and plans to do this through voluntary redundancies and the closure or sale of some operations worldwide.
* Says subsequent offering period ends on July 9 * Gets commitments to tender 2 mln more shares July 3 (Reuters) - Johnson & Johnson said about 84.
NEW BRUNSWICK, N.J., July 3 /PRwire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced that the initial offering period of its tender offer for all outstanding shares of common stock of Cougar Biotechnology, Inc.
